Allens

• Home
• About us
• Alumni
• Media
• Lawlinks
• Advanced search

• Introduction
• All Biotech News feature articles
• Biotech & Health publications
• Biotech & Health services

This page aims to help you find information from past editions of Biotech News. It lists all the feature articles we've published since our first edition. Simply click on the title to view the article you're interested in.

• Access to biological resources for biodiscovery in Queensland under scrutiny
       By Erica Davis, published 31 July 2002.
• ACIP review of enforcement of Plant Breeder's Rights
       By Dr Trevor Davies and Martin Vitins, published 29 March 2007.
• The Agricultural and Food Policy Reference Group recommends lifting GM Moratoriums
       By Dr Rob Silberstein, published 8 March 2006.
• Access to medicines and pharmaceutical patents
       By Kate Beattie, published 5 March 2003.
• AHMAC proposes new model for scheduling of drugs and poisons
       By Clare Cunliffe, published 9 August 2005.
• The ALRC Report into the Protection of Human Genetic Information
       Published 10 September 2002.
• The ALRC report into the protection of genetic information – the implications for genetic testing
       By Caroline Ryan, published 24 September 2002.
• The ALRC report into the protection of genetic information – the implications for human genetic research and genetic databases
       By Damien van der Toorn and Erica Davis, published 8 October 2002.
• The ALRC Report into the Protection of Human Genetic Information: insurance, employment and privacy implications
       By Lorien Beazley, Ben Arnall and Johanna Gibson, published 22 October 2002.
• Approaching a VC for funding
       By Lisa Keam, published 1 July 2001.
• APVMA Guidelines for the Registration of Biological Agricultural Products
       By Caroline Ryan, published 26 July 2005. 
• AusBioNSW 2005 – Sydney – 1-2 September 2005
       By Dr Kathryn Sunn and Dr Rob Silberstein
• AusBiotech 2002
       By Jeff Bergmann, published 27 August 2002.
• AusBiotech National Conference 7-10 November 2004 – Brisbane
       By Kathryn Sunn and Dr Trevor Davies, published 23 November 2004.
• Australian High Court allows Astra's Losec patent appeal
       By Cynthia Cochrane and Michael Dowling, published 18 December 2002.
• The Australian Pesticides and Veterinary Medicines Authority
       By Caroline Ryan, published 10 May 2005. 
• Back door listing – an alternative to an IPO
       By Robyn Phillips, published 16 July 2002.
• Beware the inventive marketing manager!
       By Jeff Bergmann, published 13 August 2002.
• Bio 2003 Annual Convention
       By Lorien Beazley and Dr Trevor Davies, published 8 July 2003.
• 'Biobanks' and genetic data linkage: can Australian privacy regulation keep up?
       By Karin Clark, published 10 May 2006
• Biotech – A framework for Disclosure
       By Mark Malinas, published 22 June 2004.
• The Biotechnology Centre of Excellence 
       By Sophie Chamberlin, published 21 May 2002.
• The Biotechnology Centre of Excellence
       By Johanna Gibson, published 5 November 2002.
• Brain and Mind: Innovate. Integrate. Inspire
       By AAR, published 22 July 2003.
• Branding for biotechnology innovation
      By Dr Trevor Davies and Lara Gun, published 1 August 2007
• Brave new world? – The legislative response to human cloning
       By Caroline Ryan, published 15 January 2002.
• Case study: Patent Claim specification defines the scope of patent protection
       By Anthony Selleck, published 25 May 2004.
• Case study: University of Rochester v GD Searle &Co Inc & Ors
       By Clare Cunliffe and Philip Kerr, published 8 June 2004.
• Changes to the Copyright Act 1968 directly affect the biotech and health industries
       By Alex Feltham, published 23 October 2001.
• Changes to the Therapeutic Goods Act
       By Clare Cunliffe, Robert Cooper and Richard Hamer, published 10 June 2003.
• Changes to the Therapeutic Goods Act take effect
       By Karin Clark and Jackie Mandelbaum, published 8 June 2006.
• Changes to therapeutic goods regulation
      By Andrew Gunn, published 10 August 2006
• The changing health privacy landscape: some tips (and traps)
       By Karin Clark, published 7 January 2003.
• Claiming patient records as a depreciating asset for tax purposes
       By Lorien Beazley and Mark Johnston , published 30 March 2004.
• ClubBio 2002 – Biotechnology with a Sunshine Coast twist
       By Lorien Beazley, published 19 November 2002.
• ClubBio2005 – Fever at the Frontline
       By Lorien Beazley, published 23 August 2005.
• Collaborations and licensing – key legal issues
       By Rebecca Sadleir, published 13 May 2003.
• Commercialisation strategies for Research Institutions
       By Caroline Ryan, published 29 March 2005.
• Commercialisation strategies for biotechnology companies
       By Adrian Coras, published 7 June 2007.
• The Commonwealth Research and Development Tax Concession 
       By Peter Allen and Carla Drinkwater, published 18 October 2006.  
• Conflicts of interests for scientific researchers
       By Alex Fleming, published 16 April 2003.
• Continuing Uncertainty for Pharmacies
       By Robyn Chatwood and Michael Dowling, published 28 June 2005.
• Contributory infringement in relation to patents
       By Dr Rob Silberstein, published 28 September 2007.
• Cooperative Research Centres: what they are and how they are formed
       By Bill Singleton, published 21 June 2007.
• Data exclusivity: further protection for pharmaceuticals
       By Jonathan de Ridder, published 24 June 2003.
• Disclaimers in European Patent Claims
       By Anthony Selleck, published 17 August 2004.
• Discussion: Merger of Australian and New Zealand therapeutic goods regulators
       By Annette Hughes and Susannah Downie, published 13 April 2004.
• Discussion Paper 68: Gene Patenting and Human Health 
       By Caroline Ryan, published 16 March 2004.
• Due diligence in the biotech industry
       By Matt Ireland and Pat Crisp, published 16 August 2007.
• Effective due diligence
       By Rebecca Sadleir, published 29 April 2003.
• Employee Inventions
       By Clare Cunliffe and Andrew Wiseman, published 26 April 2005. 
• Ethical conflicts in the trial arena
       By Tom Fotheringham, published 27 May 2003.
• Evergreening and the Australian Patents Act
       By Anthony Selleck, published 7 December 2004.
• Experimental use exemptions
      By Dr Trevor Davies and Ollie Evans, published 8 November 2007.
• Fast tracking procedures and orphan drug programs in the USA, EU and Australia
       By Penny Holloway and Dorothy Pawlukowski, published 1 April 2003.
• First 'go to grow' given by Gene Technology Regulator
       By Lorien Beazley, published 12 February 2002.
• Food-medicine interface
       By Alice Hume, published 16 September 2003.
• Gene patents in Australia subject to major new Australian Law Reform Commission inquiry
       By Erica Davis and Dr Trevor Davies, published 18 February 2003.
• Genes and Ingenuity: Gene Patenting and Human Health (ALRC 99)
       By Alexia Mayer and Dr Trevor Davies, published 12 October 2004.
• Genetic privacy: re-defining identification
      By Karin Clark and Andrew Ailwood, published 23 August 2006
• GM Food Regulations
       By Richard Hamer and Eloise Curry, published 24 May 2006.
• Grace periods in patent law
       By Dr Rob Silberstein, published 10 May 2007.
• Grants and Concessions – Australian State and Territory Governments 
       By Robert Silberstein, published 11 October 2006.
• Grants and Concessions – Grants and concessions – Australian Federal Government  
       By Robert Silberstein, published 6 September 2006.
• Guardianship and consent to participation in clinical trials 
       By Vasantha Stesin, published 4 June 2002.
• Health claims in relation to therapeutic goods
       By Clare Cunliffe and Guy Foster, published 30 September 2003.
• How to Apply for a Patent Amendment
       By Kate Beattie, published 3 December 2002.
• Impacts of the US Australia Free Trade Agreement on IP laws and the Pharmaceutical Benefits Scheme
       By Alice Hume, published 17 February 2004.
• How to Apply for a Patent Amendment
       By Kate Beattie, published 3 December 2002.
• Inappropriate disclosure of health information and access to medical records
       By Jacqueline Goodall, published 6 July 2007.
• Informed consent – legal issues from the sponsor's perspective (part II))
       By Vasantha Stesin, published 27 July 2001.
• Innovator company to success story – Decision making to fund and grow your business
       By Anne Donaldson, published 27 April 2004.
• Intellectual Property Laws Amendment Bill
       By Anthony Selleck, published 24 April 2006
• The IP question
       By Jeff Bergmann, published 18 June 2002.
• Insurance contracts for biotechnology companies: issues for consideration
       By Clare Cunliffe, published 4 December 2001.
• Intellectual Property Laws Amendment Bill
       By Jonathan Gottschall and Anthony Selleck, published 24 April 2006
• Junk DNA or junk debate?
       By Jeff Bergmann, published 3 September 2003.
• Laws governing release and containment of GMOs in Australia
       By Clare Cunliffe and Dr Trevor Davies, published 6 July 2004.
• Medical indemnity insurance reforms
       By Rachael Patterson, published 21 January 2003.
• Methods of treating humans: an overview of patentability in various jurisdictions 
       By Trevor Davies and John Landells, published 2 November 2006.  
• National Framework for the Development of Ethical Principles in Gene Technology
       By Caroline Ryan, published 18 October 2005.
• A new model for biotech investing? 
       By Bruce Roberts, published 19 March 2003.
• New biotechnology: how to protect from a product liability claim
       By Maryjane Crabtree, published 1 December 2005.
• New IP policy for government agencies
       By Trevor Davies and John Landells, published 19 July 2007.
• New privacy laws to govern research activities 
       By Karin Clark, published 7 September 2001.
• New United States patent rules – the battle has commenced
       By Dr Trevor Davies, published 26 November 2007.
• New Zealand Royal Commission reports on genetic modification
       By Eliza Collier, published 9 October 2001.
• No automatic defence for non-profit experimental research
       By Duncan Bucknell, published 19 August 2003.
• On the move: The transfer of Drugs between Schedules
       By Michael Seifried and Richard Hamer, published 20 July 2004.
• Overview of therapeutic cloning laws in Australia
       By Sarah Matheson and Adel Mohamed, published 7 March 2007.
• Parliament relaxes requirements for Therapeutic Goods Act patent certificates
       By Fiona Galbraith and Sarah Matheson, published 4 April 2006.
• Patents and experimental use – public consultation paper 
       By Dominic Nguyen, published 21 September 2006.  
• Patent extensions and the requirement for a pharmaceutical substance per se
       By Martin Hecht and Partner Michael Dowling, published 21 March 2006
• Patent extensions for pharmaceutical substances: when do registered goods 'contain, or consist of' a pharmaceutical substance?
       By Dr Trevor Davies and Jonathan de Ridder, published 14 December 2006
• Patentability of Methods of Medical Treatment
       By Clare Cunliffe, published 18 December 2002.
• Patenting Exclusion for Human Beings
       By Kathryn Sunn and Dr Trevor Davies , published 31 August 2004.
• Patents and Experimental Use in Australia
       By Caroline Ryan, published 8 March 2005.
• Patents and experimental use – public consultation paper
       By paper Dominic Nguyen, published 21 September 2006.
• Pharmacia Italia S.P.A v Mayne Pharma Pty Ltd [2005] FCA 1066
       By Caroline Ryan, published 6 September 2005.
• PhotoCure ASA v Queens University at Kingston [2005] FCA 344
       By Clare Cunliffe and Philip Kerr , published 24 May 2005. 
• Preparation, preparation, preparation ! Crisis management plans for therapeutic goods tampering
       By Liam Prescott and Lionel Hogg, published 6 November 2001.
• Privacy Act Under the Microscope
       By Andrew Cameron and Peter James, published 12 April 2005.
• Privacy Commissioner's biometrics recommendations in response to ALRC privacy review 
       By Peter Jones and Valeska Bloch, published 12 April 2007.
• Prohibition of Human Cloning Act 2002 – summary of principal provisions 
       By Kirraley Bowles, published 4 February 2003.
• Proposed Australian and New Zealand Therapeutic Products Authority Regulatory Scheme 
       By Kathryn Sunn,published 22 June 2006.
• Proposed Genetic Privacy and Non-Discrimination Bill 
       By Erica Davis,published 2 July 2002.
• Protecting human subjects – the new guide
       By Damien van der Toorn, published 26 March 2002.
• Protecting IP developed by employees
       By Kirraley Bowles, published 3 August 2004.
• Protection of human genetic information – will Gattaca become reality?
       By Katrina Tucker, published 18 December 2001.
• Public access to patented pharmaceuticals – the Australian climate
       By Jonathan Barlow and Miranda Harris, published 24 April 2002.
• Qld Biodiscovery Act 2004
       By Alison Rush, published 14 September 2004.
• Queensland's biotechnology Code – a legal and regulatory 'bible'?
       By Alex Feltham, published 25 September 2001.
• Queensland's ClubBio2003 - Passion, People & Products
       By Lorien Beazley, published 11 November 2003.
• Regulation of cosmetic chemicals
            By Andrew Gun and Sarah Matheson, published 21 February 2006
• Regulation of Follow-on Biologics
       By Sarah Matheson and Adel Mohamed, published 29 August 2007
• Regulation of Stem Cell Research in Australia
       By James McConvill, published 8 May 2002.
• Research Collaboration in Australian Biotechnology Part 1: Joint Ventures
       By Tony Pyman and Tamsin Hone, published 14 October 2003.
• Research Collaboration in Australian Biotechnology Part 2: Structural Issues and protection of Intellectual Property rights
       By Jacky Mandelbaum, published 28 October 2003.
• Research Collaboration in Australian Biotechnology Part 3: Commercialisation Strategies
       By Anne Donaldson, published 25 November 2003.
• Research Collaboration in Australian Biotechnology Part 4: Tax Implications
       By Grant Howden, Sarah Murray and Wei-Ee Cheah, published 10 December 2003.
• Restrictions on patenting genes in Australia: Patents Amendment Act 2001 (Cth) raises the bar
       By Erica Davis, published 12 March 2002.
• Review of Clinical Trials & Access to Unapproved Therapeutic Goods in Australia
       By Tanya Vaysman and Caroline Ryan, published 7 June 2005.
• Review of the National Component of the Gene Technology Regulatory System
       By Sarah Matheson and Caroline Ray, published 12 July 2005.
• Springboarding as an exception to patent infringement: a jurisdictional comparison
       By Sarah Matheson and Emma Stacey, published 30 November 2006.
• Stem cell legislation – A jusrisdictional comparison
       By Melissa Foong, published 2 March 2004.
• Structuring Spinoffs
       By Ian Pyman & Lisa Keam, published 13 August 2001.
• Tax Implications of Research Collaboration in Australian Biotechnology
       By Grant Howden & Sarah Murray, published 10 December 2003.
• TGA Amendments 2005
       By Lorien Beazley, published 10 October 2005.
• Therapeutic Goods Amendment Act 2007: re-evaluation of 'registered' or 'listed' devices
       By Rachel Darvey, published 26 October 2007.
• Therapeutic Goods and the Joint Tasman Agency
       By Clare Cunliffe and Philip Kerr, published 26 October 2004.
• Therapeutic Goods and the US-Australia Free Trade Agreement
       By Clare Cunliffe, published 28 September 2004.
• Transfer pricing, intellectual property and advanced pricing agreements: how business taxpayers can protect themselves
       By Monica Jordan and Marc Johnston, published 11 May 2004.
• TRIPS – What is it and why is it important to the biotech industry?
       By Erica Davis , published 20 November 2001.
• Turning a provisional application into a complete application – getting the most out of the 12 month convention period
       By Garen Holopikian, published 29 January 2002.
• Two Australian states lift moratoria on GM canola
       By Dr Trevor Davies and Elizabeth Sarofim, published 13 December 2007.
• US Lab Notebook requirements – proof of date of patentable invention
       By Jeff Bergmann , published 24 August 2001.
• US Medicare Drug Act amends patent laws to provide for timely access to generic drugs
       By Erica Davis , published 3 February 2004.
• US Patent and Trademark Office issues notice on patent application containing nucleotide sequences
       By Dr Robert Smyth and Dr Kathryn Sunn, published 28 May 2007.
• Victoria's new health information privacy laws: voluntary compliance requested from 1 March
       By Karin Clark, published 26 February 2002.
• Venture Capital Limited Partnerships – the current picture
       By Gerry Cawson, published 9 April 2002.
• WIPO Delegates bend minds to traditional knowledge
       By Anne Donaldson, published 9 November 2004.